Medartis Holding AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CH0386200239
CHF
77.90
0.5 (0.65%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
224.83
212.01
182.82
159.88
127.65
130.14
121.32
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
224.83
212.01
182.82
159.88
127.65
130.14
121.32
Raw Material Cost
63.24
60.45
47.44
38.31
33.76
28.84
26.46
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
103.42
96.74
93.65
81.00
66.64
63.20
59.95
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
6.80
1.73
4.62
1.47
1.37
1.96
1.58
Selling and Distribution Expenses
125.75
115.99
113.74
92.78
76.55
80.27
72.28
Other Expenses
-8.73
-7.43
-7.48
-6.47
-5.38
-5.15
-4.88
Total Expenditure (Excl Depreciation)
211.89
200.57
184.69
148.87
124.55
122.79
111.47
Operating Profit (PBDIT) excl Other Income
12.9
11.399999999999999
-1.9
11
3.1
7.4
9.9
Other Income
2.49
-4.22
0.30
-1.30
-5.02
-2.07
-2.11
Operating Profit (PBDIT)
37.72
28.22
16.54
26.10
13.96
18.27
15.50
Interest
6.80
1.73
4.62
1.47
1.37
1.96
1.58
Exceptional Items
-6.76
-3.13
-0.90
0.00
0.00
0.00
-3.20
Gross Profit (PBDT)
161.59
151.56
135.39
121.57
93.89
101.30
94.86
Depreciation
22.30
21.00
18.11
16.39
15.89
12.99
8.35
Profit Before Tax
1.86
2.37
-7.09
8.25
-3.30
3.32
2.37
Tax
-1.03
1.18
-1.36
1.45
-2.32
1.17
-1.83
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
3.53
0.62
-5.78
6.84
-0.94
2.15
4.20
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
3.53
0.62
-5.78
6.84
-0.94
2.15
4.20
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
3.53
0.62
-5.78
6.84
-0.94
2.15
4.20
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.2
0.2
0.2
0.2
0.2
0.2
0.2
Reserves
269.65
254.96
237.78
224.00
213.04
215.57
218.23
Earnings per share (EPS)
0.28
0.05
-0.49
0.58
-0.08
0.18
0.4
Diluted Earnings per share
0.28
0.05
-0.49
0.58
-0.08
0.18
0.4
Operating Profit Margin (Excl OI)
5.75%
5.4%
-1.02%
6.89%
2.43%
5.65%
7.63%
Gross Profit Margin
10.75%
11.02%
6.03%
15.41%
9.87%
12.53%
8.84%
PAT Margin
1.57%
0.29%
-3.16%
4.28%
-0.74%
1.65%
3.46%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 6.04% vs 15.97% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 483.33% vs 110.34% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 8.64% vs 100.00% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 300.00% vs -63.04% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Medartis Holding AG With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CHF)
Change(%)
Net Sales
224.83
445.36
-220.53
-49.52%
Other Operating Income
0.00
0.00
0.00
Total Operating income
224.83
445.36
-220.53
-49.52%
Raw Material Cost
63.24
252.26
-189.02
-74.93%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
103.42
170.60
-67.18
-39.38%
Power Cost
0
0
0.00
Manufacturing Expenses
6.80
2.34
4.46
190.60%
Selling and Distribution Expenses
125.75
94.32
31.43
33.32%
Other Expenses
-8.73
-10.57
1.84
17.41%
Total Expenditure (Excl Depreciation)
211.89
413.84
-201.95
-48.80%
Operating Profit (PBDIT) excl Other Income
12.94
31.52
-18.58
-58.95%
Other Income
2.49
12.51
-10.02
-80.10%
Operating Profit (PBDIT)
37.72
66.14
-28.42
-42.97%
Interest
6.80
2.34
4.46
190.60%
Exceptional Items
-6.76
-1.46
-5.30
-363.01%
Gross Profit (PBDT)
161.59
193.10
-31.51
-16.32%
Depreciation
22.30
22.10
0.20
0.90%
Profit Before Tax
1.86
40.23
-38.37
-95.38%
Tax
-1.03
5.12
-6.15
-120.12%
Provisions and contingencies
0
0
0.00
Profit After Tax
3.53
35.12
-31.59
-89.95%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
3.53
35.12
-31.59
-89.95%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
3.53
35.12
-31.59
-89.95%
Equity Capital
0
0
0.00
Face Value
0.20
1.00
0.00
Reserves
269.65
325.44
-55.79
-17.14%
Earnings per share (EPS)
0.28
4.52
-4.24
-93.81%
Diluted Earnings per share
0.28
4.52
-4.24
-93.81%
Operating Profit Margin (Excl OI)
5.75%
7.08%
0.00
-1.33%
Gross Profit Margin
10.75%
14.00%
0.00
-3.25%
PAT Margin
1.57%
7.89%
0.00
-6.32%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 22.48 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 6.04% vs 15.97% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 0.35 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 483.33% vs 110.34% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.52 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 8.64% vs 100.00% in Dec 2023

Annual - Interest
Interest 0.68 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 300.00% vs -63.04% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 5.75%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023